Company Profiles

driven by the PitchBook Platform

AtoxBio

Description

Developer of therapeutics for diseases mediated by inflammatory response. The company focuses on developing novel modulators of immune response that target multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases.

2003

Founded

PRIVATE

Status

11-50

Employees

Series E

Latest Deal Type

$23M

Latest Deal Amount

$28.4M

Total Amount Raised

Description

Developer of therapeutics for diseases mediated by inflammatory response. The company focuses on developing novel modulators of immune response that target multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases.

Website:

www.atoxbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

8 Pinhas Sapir Street Weizmann Science Park Ness Ziona 7403631Israel +972 (0)8 648 4111
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AtoxBio's full profile, request a free trial.

AtoxBio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AtoxBio Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Defense Advanced Research Projects AgencyGovernment000 0000000 0000
Esperante VenturesVenture CapitalMinority000 0000000 0000
Integra HoldingsVenture CapitalMinority000 0000000 0000
Lundbeckfond VenturesVenture CapitalMinority000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
Defense Advanced Research Projects Agency Government
Esperante Ventures Venture Capital
Integra Holdings Venture Capital
Lundbeckfond Ventures Venture Capital
National Institute Of Allergy and Infectious Diseases Extramural Activites Government

AtoxBio Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Dan TelemanCo-Founder & Chief Executive Officer
Esti HayunChief Financial Officer
Gila AradCo-Founder, Scientific Consulter and Director of Research and Development
Raymond Kaempfer Ph.DScientific Founder
Anat Shirvan Ph.DExecutive Vice President, Research & Development
Dan Teleman Co-Founder & Chief Executive Officer
Esti Hayun Chief Financial Officer
Gila Arad Co-Founder, Scientific Consulter and Director of Research and Development
Raymond Kaempfer Ph.D Scientific Founder
Anat Shirvan Ph.D Executive Vice President, Research & Development

AtoxBio Board Members (9)

NameRepresentingRoleSinceContact
Info
Bob TrachtenbergSelfBoard Member000 0000
Casper BreumLundbeckfond VenturesSenior Partner000 0000
Dane RossAtoxBioBoard Member000 0000
Daniel BurgessSelfChairman000 0000
Dean SlagelEsperante VenturesManaging Director000 0000
Bob Trachtenberg Board Member Self
Casper Breum Senior Partner Lundbeckfond Ventures
Dane Ross Board Member AtoxBio
Daniel Burgess Chairman Self
Dean Slagel Managing Director Esperante Ventures
Request full access to PitchBook